COMPANY
HeartFlow
HeartFlow makes AI-based software that turns a coronary CT angiography (CCTA) scan into a 3D model of the heart, with FFRCT and plaque analyses used to assess coronary artery disease. From company website Source · Oct 12, 2026
Since the raise (Aug 11, 2025): 104 of 104 open jobs were first seen after it.
Hiring
| Title | Location (from posting) | Employer posted | First seen |
|---|---|---|---|
| Territory Account Manager - North Chicago, IL | North Chicago, IL | Oct 21, 2026 | Oct 22, 2026 |
| Territory Account Manager - Cherry Hill, NJ | Cherry Hill, NJ | Oct 21, 2026 | Oct 22, 2026 |
| IT Director, Infrastructure and Operations | Rohnert Park, California | Oct 20, 2026 | Oct 21, 2026 |
| Senior Regulatory Labeling Specialist | San Francisco, California; Rohnert Park, California | Oct 19, 2026 | Oct 20, 2026 |
| Territory Account Manager - Seattle, WA; Bellevue, WA; Everett, WA | Seattle, WA; Bellevue, WA; Everett, WA | Oct 19, 2026 | Oct 20, 2026 |
Timeline
- Trial start Not phased (device or behavioral study): REFINE-CAC Protocol: Risk Evaluation With AI-CPA + HCS For Patients IN Whom Calcium is confirmEd to Improve Coronary Artery Disease Care source ↗
- Board tracked Radar started tracking this company’s job board (104 open jobs at last check). source ↗
- Trial start Not phased (device or behavioral study): REWRITE-CAD Protocol: Risk Evaluation With AI-CPA to Reduce Progression and Improve Lifetime Care for Patients With Known Coronary Artery Disease source ↗
- Trial start —: The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI source ↗
- Raise IPO: $364.2M (total, as published), announced Aug 11, 2025. Source: company release on GlobeNewswire. source ↗
- Trial start —: Using CTA Measures to Define Cardiac Risk In NFL Alumni source ↗
- Trial start —: AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management source ↗
- Trial start —: Assessing Diagnostic Value of Non-invasive FFR-CT in Coronary Care in the Emergency Department source ↗
- Trial start —: The REVEALPLAQUE Study: A pRospEctiVe, multicEnter Study to AnaLyze PLAQUE Using CCTA source ↗
- Trial start Not phased (device or behavioral study): The PRECISE Protocol: Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization source ↗
- Trial start —: Assessing Diagnostic Value of Non-invasive FFRCT in Coronary Care source ↗
- Trial start —: The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts) source ↗
- Trial start Not phased (device or behavioral study): HeartFlowNXT - HeartFlow Analysis of Coronary Blood Flow Using Coronary CT Angiography source ↗
- Trial start Not phased (device or behavioral study): Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography source ↗
Upcoming milestones
- Dec 31, 2026 (ESTIMATED) · · Using CTA Measures to Define Cardiac Risk In NFL Alumni · NCT06831409
- 2027-10 (ESTIMATED) · Not phased · REWRITE-CAD Protocol: Risk Evaluation With AI-CPA to Reduce Progression and Improve Lifetime Care for Patients With Known Coronary Artery Disease · NCT07834372
- 2029-06 (ESTIMATED) · Not phased · REFINE-CAC Protocol: Risk Evaluation With AI-CPA + HCS For Patients IN Whom Calcium is confirmEd to Improve Coronary Artery Disease Care · NCT07853716
Open jobs 104
| Title | Location (from posting, not HQ) | Employer posted | First seen | Level |
|---|---|---|---|---|
| Territory Account Manager - North Chicago, IL | North Chicago, IL | Oct 21, 2026 | Oct 22, 2026 | Not stated |
| Territory Account Manager - Cherry Hill, NJ | Cherry Hill, NJ | Oct 21, 2026 | Oct 22, 2026 | Not stated |
| IT Director, Infrastructure and Operations | Rohnert Park, California | Oct 20, 2026 | Oct 21, 2026 | Not stated |
| Senior Regulatory Labeling Specialist | San Francisco, California; Rohnert Park, California | Oct 19, 2026 | Oct 20, 2026 | Not stated |
| Territory Account Manager - Seattle, WA; Bellevue, WA; Everett, WA | Seattle, WA; Bellevue, WA; Everett, WA | Oct 19, 2026 | Oct 20, 2026 | Not stated |
| Territory Account Manager - Atlantic City, NJ | Atlantic City, NJ | Oct 19, 2026 | Oct 20, 2026 | Not stated |
| Principal Clinical Engineer – AI Performance & Investigations | San Francisco, California | Oct 16, 2026 | Oct 17, 2026 | Not stated |
| Territory Account Manager - Buffalo, NY | Buffalo, NY | Oct 15, 2026 | Oct 16, 2026 | Not stated |
| Senior Platform Engineer (Cloud Foundations) | San Francisco, California | Oct 14, 2026 | Oct 15, 2026 | Senior |
| Territory Account Manager - Philadelphia, PA Metro/Main Line | Philadelphia, PA Metro/Main Line | Oct 13, 2026 | Oct 14, 2026 | Senior |
| Senior Product Marketing Manager - Plaque | San Francisco, California | Oct 12, 2026 | Oct 13, 2026 | Senior |
| Field Reimbursement Manager - Southwest | Houston, Texas; Dallas, Texas; Austin, Texas; Denver, Colorado; Phoenix, Arizona; Scottsdale, Arizona | Oct 12, 2026 | Oct 12, 2026 | Mid |
| Territory Sales Manager - Lincoln, NE; Omaha, NE; Des Moines, IA | Lincoln, NE; Omaha, NE; Des Moines, IA | Oct 9, 2026 | Oct 10, 2026 | Not stated |
| Territory Account Manager - North Phoenix, AZ | North Phoenix, AZ | Oct 9, 2026 | Oct 9, 2026 | Senior |
| Senior Systems Engineer | San Francisco, California | Oct 9, 2026 | Oct 9, 2026 | Senior |
| Regional Business Manager - Central | St. Louis, MO; Minneapolis, MN | Oct 9, 2026 | Oct 9, 2026 | Senior |
| Senior Software Engineer | San Francisco, California | Oct 6, 2026 | Oct 9, 2026 | Senior |
| Junior Automation Engineer | San Francisco, California | Oct 6, 2026 | Oct 9, 2026 | Entry |
| Manager, Corporate Strategy - MBA Grad, Summer 2027 | Rohnert Park, California; San Francisco, California | Oct 6, 2026 | Oct 9, 2026 | Mid |
| Product Marketing Manager - MBA Grad, Summer 2027 | San Francisco, California; Rohnert Park, California | Oct 6, 2026 | Oct 9, 2026 | Mid |
| Commercial Excellence Coordinator | United States | Oct 6, 2026 | Oct 9, 2026 | Entry |
| Product Manager - MBA Grad, Summer 2027 | San Francisco, California; Rohnert Park, California | Oct 6, 2026 | Oct 9, 2026 | Mid |
| Manager, Commercial Enablement & Strategy - MBA Grad, Summer 2027 | Rohnert Park, California; San Francisco, California | Oct 6, 2026 | Oct 9, 2026 | Mid |
| Test Architect | San Francisco, California | Oct 6, 2026 | Oct 9, 2026 | Senior |
| Territory Account Manager - North New York City, NY | North New York City, NY | Oct 5, 2026 | Oct 9, 2026 | Senior |
| Senior Technical Project Manager | San Francisco, California | Oct 5, 2026 | Oct 9, 2026 | Senior |
| Senior Software Engineer | San Francisco, California | Oct 5, 2026 | Oct 9, 2026 | Senior |
| Staff Software Engineer – Frontend | San Francisco, California | Oct 5, 2026 | Oct 9, 2026 | Senior |
| Field Reimbursement Manager - Northeast | New York City, New York; Boston, Massachusetts; Hartford, Connecticut; Portland, Maine; | Oct 5, 2026 | Oct 9, 2026 | Mid |
| Senior Product Marketing Manager - Workflow | San Francisco, California | Oct 2, 2026 | Oct 9, 2026 | Senior |
| Senior/Staff Software Engineer | San Francisco, California | Oct 1, 2026 | Oct 9, 2026 | Mid |
| Complaint Specialist | Austin, Texas | Oct 1, 2026 | Oct 9, 2026 | Entry |
| Principal Regulatory Affairs Specialist | San Francisco, California; Rohnert Park, California | Sep 30, 2026 | Oct 9, 2026 | Senior |
| Manager, Leadership Development & Sales Training | United States | Sep 29, 2026 | Oct 9, 2026 | Senior |
| Manager, Digital Learning & Program Development | United States | Sep 29, 2026 | Oct 9, 2026 | Senior |
| Territory Account Manager - Charleston, SC | Charleston, SC | Sep 28, 2026 | Oct 9, 2026 | Senior |
| Director, Customer Support | Austin, Texas, United States | Sep 25, 2026 | Oct 9, 2026 | Senior |
| IT Director, Salesforce Platform Owner | Rohnert Park, California | Sep 24, 2026 | Oct 9, 2026 | Senior |
| Territory Account Manager - Peoria, IL; Champaign, IL | Peoria, IL; Champaign, IL | Sep 24, 2026 | Oct 9, 2026 | Senior |
| Territory Account Manager - St. Louis, MO; Columbia, MO | St. Louis, MO; Columbia, MO | Sep 24, 2026 | Oct 9, 2026 | Senior |
| Clinical Field Specialist, CT - Texas | San Antonio, Texas, United States | Sep 23, 2026 | Oct 9, 2026 | Mid |
| Finance Manager | San Francisco, California; Rohnert Park, California | Sep 23, 2026 | Oct 9, 2026 | Mid |
| Senior Finance Manager | San Francisco, California; Rohnert Park, California | Sep 23, 2026 | Oct 9, 2026 | Senior |
| Senior Data Scientist, Medical Imaging | San Francisco, California | Sep 21, 2026 | Oct 9, 2026 | Senior |
| Territory Sales Manager - New Mexico/El Paso | El Paso, Texas | Sep 17, 2026 | Oct 9, 2026 | Senior |
| Territory Sales Manager - Atlanta | Atlanta, GA | Sep 17, 2026 | Oct 9, 2026 | Senior |
| Director, Clinical Quality & Compliance | San Francisco, California | Sep 15, 2026 | Oct 9, 2026 | Senior |
| Territory Account Manager - Fresno, CA | Fresno, CA | Sep 15, 2026 | Oct 9, 2026 | Senior |
| Territory Account Manager - Spokane, WA | Spokane, WA | Sep 15, 2026 | Oct 9, 2026 | Senior |
| Territory Account Manager - East Bay | Pleasanton, CA; Walnut Creek, CA; Modesto, CA | Sep 15, 2026 | Oct 9, 2026 | Senior |
Funding
- IPO: $364.2M (total, as published), announced Aug 11, 2025. Source: company release on GlobeNewswire. source ↗
Clinical trials (lead sponsor) 12
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT07853716 | REFINE-CAC Protocol: Risk Evaluation With AI-CPA + HCS For Patients IN Whom Calcium is confirmEd to Improve Coronary Artery Disease Care | Not phased (device or behavioral study) | Not yet recruiting | 2026-11 | 2029-06 (estimated) |
| NCT07834372 | REWRITE-CAD Protocol: Risk Evaluation With AI-CPA to Reduce Progression and Improve Lifetime Care for Patients With Known Coronary Artery Disease | Not phased (device or behavioral study) | Not yet recruiting | 2026-10 | 2027-10 (estimated) |
| NCT06376851 | AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management | Not listed | Active, not recruiting | Mar 27, 2024 | Mar 27, 2026 (actual) |
| NCT05325112 | Assessing Diagnostic Value of Non-invasive FFR-CT in Coronary Care in the Emergency Department | Not listed | Terminated | Jul 15, 2022 | Nov 14, 2022 (actual) |
| NCT07479433 | The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI | Not listed | Recruiting | Mar 11, 2026 | Sep 30, 2026 (estimated) |
| NCT01943903 | The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts) | Not listed | Completed | 2013-09 | 2015-12 (actual) |
| NCT06831409 | Using CTA Measures to Define Cardiac Risk In NFL Alumni | Not listed | Recruiting | Dec 17, 2024 | Dec 31, 2026 (estimated) |
| NCT05138289 | The REVEALPLAQUE Study: A pRospEctiVe, multicEnter Study to AnaLyze PLAQUE Using CCTA | Not listed | Completed | Oct 12, 2021 | Nov 8, 2022 (actual) |
| NCT02499679 | Assessing Diagnostic Value of Non-invasive FFRCT in Coronary Care | Not listed | Completed | 2015-07 | 2019-02 (actual) |
| NCT03702244 | The PRECISE Protocol: Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization | Not phased (device or behavioral study) | Completed | Nov 27, 2018 | May 20, 2022 (actual) |
| NCT01233518 | Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography | Not phased (device or behavioral study) | Completed | 2010-10 | 2011-11 (actual) |
| NCT01757678 | HeartFlowNXT - HeartFlow Analysis of Coronary Blood Flow Using Coronary CT Angiography | Not phased (device or behavioral study) | Completed | 2012-09 | 2013-09 (actual) |
Raises and investors new
- InvestorListed in the portfolio of Bain Capital Life Sciences (captured Oct 12, 2026). portfolio page ↗
Connect
See your connections at HeartFlow on LinkedIn (search by name, results not checked)